Everyone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the market in late 2022. You might think it’s way too late to invest in AI. But here’s the thing.

PTGX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 5.40%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $15,191,715.79

Protagonist Therapeutics Insider Trading History Chart

Protagonist Therapeutics Share Price & Price History

^$41.49

▲ +1.95 (4.93%)

As of 12/20/2024 06:16 PM ET

Days: 30 | 90 | 365

Did You See Trump’s Bombshell Exec. Order 001?

From Banyan Hill Publishing | Ad

Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minutes of stepping into the Oval Office...

I put all the details together for you here — but please hurry.

Protagonist Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/27/2024	Arturo Md Molina	Insider	Sell	26,000	$44.70	$1,162,200.00	46,444
11/25/2024	Dinsesh V. Patel	CEO	Sell	78,520	$46.96	$3,687,299.20	435,208
11/25/2024	Suneel Gupta	Insider	Sell	103,437	$46.04	$4,762,239.48	256,174
11/15/2024	Arturo Md Molina	Insider	Sell	1,906	$40.98	$78,107.88	46,444
9/11/2024	Asif Ali	CFO	Sell	14,203	$44.49	$631,891.47	34,960
9/10/2024	William D. Waddill	Director	Sell	8,000	$45.00	$360,000.00	12,000
7/24/2024	William D. Waddill	Director	Sell	8,000	$40.00	$320,000.00	12,000
6/7/2024	Dinsesh V. Patel	CEO	Sell	35,000	$35.19	$1,231,650.00	515,415
6/7/2024	William D. Waddill	Director	Sell	8,000	$35.00	$280,000.00	12,000
4/18/2024	Asif Ali	CFO	Sell	1,234	$25.11	$30,985.74	37,163
4/1/2024	Dinsesh V. Patel	CEO	Sell	25,000	$28.31	$707,750.00	549,590
3/1/2024	Asif Ali	CFO	Sell	14,248	$32.24	$459,355.52	38,397
3/1/2024	Dinsesh V. Patel	CEO	Sell	30,000	$31.62	$948,600.00	574,590
3/1/2024	William D. Waddill	Director	Sell	12,975	$31.34	$406,636.50	12,000
1/9/2024	Suneel Gupta	Insider	Sell	5,000	$25.00	$125,000.00	187,567
12/21/2021	Dinsesh V. Patel	CEO	Sell	15,000	$32.14	$482,100.00

Did You See Trump’s Bombshell Exec. Order 001?

From Banyan Hill Publishing | Ad

Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minutes of stepping into the Oval Office...

I put all the details together for you here — but please hurry.

SEC Filings (Institutional Ownership Changes) for Protagonist Therapeutics (NASDAQ:PTGX)

98.63% of Protagonist Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Protagonist Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
12/19/2024	Principal Financial Group Inc.	320,832	$14.44M	0.0%	+3,099.4%	0.538%
11/27/2024	Franklin Resources Inc.	81,591	$3.78M	0.0%	+127.2%	0.137%
11/18/2024	Teachers Retirement System of The State of Kentucky	20,200	$0.91M	0.0%	N/A	0.034%
11/16/2024	Geode Capital Management LLC	1,374,697	$61.87M	0.0%	+0.3%	2.307%
11/15/2024	Barclays PLC	126,995	$5.71M	0.0%	+223.6%	0.213%
11/15/2024	Y Intercept Hong Kong Ltd	5,251	$0.24M	0.0%	-89.1%	0.009%
11/15/2024	Orion Portfolio Solutions LLC	6,114	$0.28M	0.0%	-17.2%	0.010%
11/15/2024	XTX Topco Ltd	14,801	$0.67M	0.0%	N/A	0.025%
11/15/2024	Jane Street Group LLC	32,858	$1.48M	0.0%	-74.0%	0.055%
11/15/2024	Wellington Management Group LLP	30,079	$1.35M	0.0%	N/A	0.050%
11/15/2024	Weiss Asset Management LP	62,463	$2.81M	0.1%	N/A	0.105%
11/15/2024	State Street Corp	3,183,542	$143.26M	0.0%	+52.9%	5.342%
11/15/2024	RTW Investments LP	5,426,112	$244.18M	3.5%	+2.6%	9.104%
11/15/2024	Point72 Asset Management L.P.	214,872	$9.67M	0.0%	-76.4%	0.361%
11/15/2024	Jacobs Levy Equity Management Inc.	128,654	$5.79M	0.0%	-0.3%	0.216%
11/15/2024	HighTower Advisors LLC	10,887	$0.49M	0.0%	-54.2%	0.018%
11/15/2024	HighVista Strategies LLC	89,508	$4.03M	1.4%	+321.6%	0.150%
11/15/2024	Checkpoint Capital L.P.	240,000	$10.80M	5.4%	-32.4%	0.403%
11/15/2024	Point72 Asia Singapore Pte. Ltd.	2,699	$0.12M	0.0%	-81.5%	0.005%
11/14/2024	Bellevue Group AG	12,346	$0.56M	0.0%	-18.5%	0.021%
11/14/2024	Point72 Europe London LLP	45,317	$2.04M	0.1%	N/A	0.076%
11/14/2024	Walleye Capital LLC	105,335	$4.74M	0.0%	N/A	0.177%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	368,132	$16.57M	0.0%	-0.5%	0.618%
11/14/2024	Public Sector Pension Investment Board	124,949	$5.62M	0.0%	N/A	0.210%
11/13/2024	Glenmede Trust Co. NA	14,981	$0.67M	0.0%	-3.4%	0.025%
11/13/2024	BNP Paribas Financial Markets	20,294	$0.91M	0.0%	+448.9%	0.034%
11/13/2024	FMR LLC	454,196	$20.44M	0.0%	+4.5%	0.762%
11/13/2024	Advantage Alpha Capital Partners LP	11,336	$0.51M	0.1%	N/A	0.019%
11/13/2024	The Manufacturers Life Insurance Company	115,765	$5.21M	0.0%	+1.2%	0.194%
11/13/2024	Harvest Fund Management Co. Ltd	1,544	$69K	0.0%	N/A	0.003%
11/12/2024	Swedbank AB	50,000	$2.25M	0.0%	N/A	0.085%
11/12/2024	Algert Global LLC	115,679	$5.21M	0.1%	-23.9%	0.196%
11/12/2024	Cerity Partners LLC	14,241	$0.64M	0.0%	+26.7%	0.024%
11/12/2024	Eagle Asset Management Inc.	294,280	$13.61M	0.1%	-17.7%	0.500%
11/12/2024	Charles Schwab Investment Management Inc.	565,503	$25.45M	0.0%	+7.6%	0.960%
11/12/2024	Pacer Advisors Inc.	1,734,090	$78.03M	0.2%	+405,061.2%	2.944%
11/9/2024	Intech Investment Management LLC	19,128	$0.86M	0.0%	N/A	0.032%
11/8/2024	BNP PARIBAS ASSET MANAGEMENT Holding S.A.	125,898	$5.67M	0.0%	N/A	0.214%
11/8/2024	Moran Wealth Management LLC	15,030	$0.68M	0.0%	+27.6%	0.026%
11/8/2024	Segall Bryant & Hamill LLC	120,301	$5.41M	0.1%	+1.5%	0.204%
11/7/2024	Quest Partners LLC	23,947	$1.08M	0.1%	+885.1%	0.041%
11/7/2024	Thrivent Financial for Lutherans	46,257	$2.08M	0.0%	N/A	0.079%
11/6/2024	Mutual of America Capital Management LLC	8,860	$0.40M	0.0%	N/A	0.015%
11/6/2024	King Wealth Management Group	6,000	$0.27M	0.0%	-50.0%	0.010%
11/5/2024	Victory Capital Management Inc.	130,797	$5.89M	0.0%	+1,729.3%	0.222%
11/5/2024	Entropy Technologies LP	6,929	$0.31M	0.0%	N/A	0.012%
11/4/2024	Los Angeles Capital Management LLC	22,446	$1.01M	0.0%	-27.2%	0.038%
10/31/2024	Financial Enhancement Group LLC	41,818	$1.88M	0.3%	N/A	0.071%
10/30/2024	Amalgamated Bank	17,324	$0.78M	0.0%	+756.4%	0.030%
10/29/2024	Janney Montgomery Scott LLC	19,249	$0.87M	0.0%	N/A	0.033%
10/28/2024	US Bancorp DE	7,866	$0.35M	0.0%	-8.2%	0.013%
10/28/2024	Palumbo Wealth Management LLC	5,211	$0.23M	0.1%	N/A	0.009%
10/25/2024	New York State Teachers Retirement System	24,592	$1.11M	0.0%	N/A	0.042%
10/25/2024	China Universal Asset Management Co. Ltd.	11,329	$0.51M	0.1%	+64.4%	0.019%
10/24/2024	Cavalier Investments LLC	29,956	$1.35M	0.4%	N/A	0.051%
10/24/2024	State of Alaska Department of Revenue	33,615	$1.51M	0.0%	N/A	0.057%
10/23/2024	Mirae Asset Global Investments Co. Ltd.	2,130	$95K	0.0%	+21.6%	0.004%
10/23/2024	Louisiana State Employees Retirement System	28,500	$1.28M	0.0%	N/A	0.048%
10/23/2024	Moody Aldrich Partners LLC	119,287	$5.37M	1.0%	-11.1%	0.203%
10/23/2024	Hennion & Walsh Asset Management Inc.	37,413	$1.68M	0.1%	-1.2%	0.064%
10/21/2024	Everence Capital Management Inc.	7,050	$0.32M	0.0%	N/A	0.012%
10/19/2024	Allspring Global Investments Holdings LLC	103,842	$4.67M	0.0%	+24,162.1%	0.176%
10/16/2024	Bleakley Financial Group LLC	7,031	$0.32M	0.0%	N/A	0.012%
10/15/2024	Swedbank AB	50,000	$2.25M	0.0%	N/A	0.085%
10/11/2024	Creative Planning	7,504	$0.34M	0.0%	N/A	0.013%
10/10/2024	Exchange Traded Concepts LLC	961	$43K	0.0%	N/A	0.002%
10/10/2024	Inspire Investing LLC	36,514	$1.64M	0.2%	+256.8%	0.062%
10/8/2024	CWM LLC	1,273	$57K	0.0%	+910.3%	0.002%
10/7/2024	GAMMA Investing LLC	552	$25K	0.0%	+749.2%	0.001%
10/3/2024	SG Americas Securities LLC	25,740	$1.16M	0.0%	+135.0%	0.044%
9/16/2024	Point72 DIFC Ltd	4,415	$0.15M	0.0%	N/A	0.007%
9/16/2024	Cubist Systematic Strategies LLC	84,202	$2.92M	0.0%	+1,304.5%	0.143%
8/16/2024	Perceptive Advisors LLC	1,268,735	$43.96M	1.0%	+27.6%	2.154%
8/16/2024	Northwestern Mutual Wealth Management Co.	157,788	$5.47M	0.0%	N/A	0.268%
8/16/2024	Algert Global LLC	152,079	$5.27M	0.2%	+2.9%	0.258%
8/16/2024	Driehaus Capital Management LLC	556,835	$19.29M	0.2%	-0.7%	0.945%
8/15/2024	The Manufacturers Life Insurance Company	114,406	$3.96M	0.0%	+27.6%	0.194%
8/15/2024	Millennium Management LLC	958,283	$33.21M	0.0%	+2,135.6%	1.627%
8/15/2024	Dark Forest Capital Management LP	60,962	$2.11M	0.4%	N/A	0.104%
8/15/2024	AQR Capital Management LLC	25,055	$0.87M	0.0%	-69.1%	0.043%
8/15/2024	Point72 Asia Singapore Pte. Ltd.	14,556	$0.50M	0.1%	N/A	0.025%
8/14/2024	Squarepoint Ops LLC	9,823	$0.34M	0.0%	N/A	0.017%
8/14/2024	Point72 Asset Management L.P.	909,734	$31.52M	0.1%	-24.2%	1.545%
8/14/2024	Cubist Systematic Strategies LLC	84,202	$2.92M	0.0%	+1,304.5%	0.143%
8/14/2024	Point72 DIFC Ltd	4,415	$0.15M	0.0%	N/A	0.007%
8/14/2024	Marshall Wace LLP	572,177	$19.83M	0.0%	-41.4%	0.971%
8/14/2024	Farallon Capital Management LLC	5,840,773	$202.38M	1.0%	+1.8%	9.916%
8/14/2024	ProShare Advisors LLC	11,270	$0.39M	0.0%	-21.4%	0.019%
8/14/2024	Profund Advisors LLC	14,529	$0.50M	0.0%	-61.2%	0.025%
8/12/2024	Inspire Investing LLC	10,234	$0.36M	0.0%	-17.1%	0.017%
8/12/2024	Seven Eight Capital LP	36,793	$1.28M	0.1%	+426.9%	0.063%
8/12/2024	Hsbc Holdings PLC	7,529	$0.26M	0.0%	-93.3%	0.013%
8/9/2024	Renaissance Technologies LLC	297,467	$10.31M	0.0%	+813.4%	0.507%
8/9/2024	Dimensional Fund Advisors LP	616,172	$21.35M	0.0%	-22.1%	1.051%
8/8/2024	American Century Companies Inc.	27,311	$0.95M	0.0%	-83.0%	0.047%
8/7/2024	Cowen AND Company LLC	1,182,268	$40.97M	1.1%	-24.1%	2.016%
8/6/2024	Quest Partners LLC	2,431	$84K	0.0%	-58.8%	0.004%
8/6/2024	Great Lakes Advisors LLC	93,479	$3.24M	0.0%	-3.8%	0.159%
8/6/2024	Candriam S.C.A.	273,818	$9.49M	0.1%	-23.9%	0.467%
8/5/2024	Arizona State Retirement System	12,236	$0.42M	0.0%	-3.5%	0.021%

Data available starting January 2016

Protagonist Therapeutics, Inc., a biopharmaceutical company, develops peptide-based drugs for hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing Rusfertide (PTG-300), an injectable hepcidin mimetic that completed phase 2 clinical trials for the treatment of polycythemia vera and other blood disorders; and JNJ-2113, an orally delivered investigational drug to block biological pathways that completed phase 2b clinical trials for the treatment of moderate-to-severe plaque psoriasis; and PN-943, an orally delivered, gut-restricted alpha 4 beta 7 specific integrin antagonist completed a phase 2 clinical trials in patients with moderate to severe ulcerative colitis. The company has a license and collaboration agreement with Takeda to commercialize rusfertide; and JNJ Innovative Medicines to co-develop Interleukin-23 receptor antagonist compound JNJ-2113. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California.

Today's Range

Now: $41.49

$38.91

$41.68

50 Day Range

MA: $44.02

$38.65

$48.43

52 Week Range

Now: $41.49

$20.88

$48.89

Volume

2,360,707 shs

Average Volume

748,240 shs

Market Capitalization

$2.47 billion

P/E Ratio

15.60

Dividend Yield

N/A

Beta

2.18

Who are the company insiders with the largest holdings of Protagonist Therapeutics?: Protagonist Therapeutics' top insider investors include:
Dinesh V Ph D Patel (CEO)
Suneel Gupta (Insider)
Arturo Md Molina (Insider)
Asif Ali (CFO)
William D Waddill (Director)
Learn More about top insider investors at Protagonist Therapeutics.
Who are the major institutional investors of Protagonist Therapeutics?: Protagonist Therapeutics' top institutional shareholders include:
RTW Investments LP — 9.10%
State Street Corp — 5.34%
Pacer Advisors Inc. — 2.94%
Geode Capital Management LLC — 2.31%
Charles Schwab Investment Management Inc. — 0.96%
FMR LLC — 0.76%
Learn More about top institutional investors of Protagonist Therapeutics stock.
Which major investors are selling Protagonist Therapeutics stock?: Within the previous quarter, PTGX stock was sold by these institutional investors:
Point72 Asset Management L.P.
Checkpoint Capital L.P.
Jane Street Group LLC
Eagle Asset Management Inc.
Y Intercept Hong Kong Ltd
Algert Global LLC
Moody Aldrich Partners LLC
HighTower Advisors LLC
During the previous year, company insiders that have sold Protagonist Therapeutics company stock include:
Dinesh V Ph D Patel (CEO)
Suneel Gupta (Insider)
Arturo Md Molina (Insider)
Asif Ali (CFO)
William D Waddill (Director)
Learn More investors selling Protagonist Therapeutics stock.
Which major investors are buying Protagonist Therapeutics stock?: Within the last quarter, PTGX stock was bought by institutional investors including:
Pacer Advisors Inc.
State Street Corp
Principal Financial Group Inc.
RTW Investments LP
BNP PARIBAS ASSET MANAGEMENT Holding S.A.
Public Sector Pension Investment Board
Victory Capital Management Inc.
Walleye Capital LLC

AI breakthrough about to upend industry

From Porter & Company | Ad

I urge you to watch it now.